{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:47:24Z","timestamp":1779364044913,"version":"3.53.0"},"reference-count":0,"publisher":"Portico","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2021.57.6.3264117","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T06:10:03Z","timestamp":1623132603000},"page":"387","source":"Crossref","is-referenced-by-count":15,"title":["Onasemnogene abeparvovec-xioi: a gene replacement strategy for the\ntreatment of infants diagnosed with spinal muscular atrophy"],"prefix":"10.3730","volume":"57","author":[{"family":"Schwartz, M.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Likhite, S.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Meyer, K.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1320","published-online":{"date-parts":[[2021]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:05:34Z","timestamp":1685451934000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dd8gxs"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2021.57.6.3264117","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}